ENTERIS BIOPHARMA, INTELLIGENT SOLUTIONS FOR ORAL DRUG DELIVERY
Dead / Cancelled — Cancelled — Section 8 (as of 28 Feb 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86027541
- Registration number
- 4585894
- Mark type
- Stylized text
- Filed
- 02 Aug 2013
- Published for opposition
- 01 Apr 2014
- Registered
- 12 Aug 2014
- Attorney of record
- David J. Dykeman
Goods and services
- Class 042 — Scientific and technological services: Research and development of oral drug formulations and pharmaceuticals
Owner
- Enteris BioPharma, Inc., Boonton, NJ, US
- Enteris BioPharma, Inc., Boonton, NJ, US
- Enteris BioPharma, Inc., Boonton, NJ, US
Prosecution history
- 28 Feb 2025 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 12 Aug 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 05 Aug 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 05 Aug 2020 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 05 Aug 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 May 2020 — TEAS SECTION 8 & 15 RECEIVED
- 12 Aug 2019 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Jul 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Jul 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 12 Aug 2014 — REGISTERED-PRINCIPAL REGISTER
- 11 Jul 2014 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
- 10 Jul 2014 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Jul 2014 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Jun 2014 — USE AMENDMENT FILED
- 30 Jun 2014 — CASE ASSIGNED TO INTENT TO USE PARALEGAL